|
Box | Folder
|
Title
|
| |
Series 1: Personal and Biographical,
1933-2008 [series]:
|
| 1 |
1 |
Biographical sketches,
1993-1998
|
| 1 |
2 |
Scrapbook,
1950-1973
|
| 1 |
3-6 |
CVs and bibliography,
1987-2004
|
| 1 |
7 |
High school essays,
1940-1941
|
| 1 |
8 |
University of Chicago - correspondence,
1942-1949
|
| 1 |
9 |
University of Chicago Medical and Biological Sciences Alumni Association - reunion class of 1947 - dinner menu and yearbook,
1997
|
| 1 |
10-12 |
University of Chicago - course notes, lab procedures, dietary formulations,
1948-1950
|
| 69 |
1 |
Sydenham Hospital patient records,
1948 [RESTRICTED PHI POLICY]
|
| 1 |
13 |
Medical license,
1976-1994
|
| 1 |
14 |
Army discharge,
1946
|
| 1 |
15-22 |
U.S. Army service in Korea - correspondence, orders, data,
1949-1955
|
| 69 |
3 |
U.S. Army - Korea - Q fever and scrub typhus,
1953 [RESTRICTED PHI POLICY]
|
| 1 |
23-26 |
University of Cincinnati College of Medicine fellow - correspondence, reports,
1950-1952
|
| 1 |
27 |
Children's Hospital Research Foundation - correspondence,
1955-1956
|
| 69 |
4 |
University of Cincinnati College of Medicine,
1955 [RESTRICTED PHI POLICY]
|
| 1 |
28-30 |
Johns Hopkins - correspondence, laboratory manual, notes,
1956-1957
|
| 1 |
31-34 |
PHS Commissioned Officer - orders, correspondence, identification, retirement,
1957-1988
|
| 1 |
35-37 |
National Institute of Allergies and Infectious Diseases Oral History Interview - conducted by Peggy Dillon,
2001-2003
|
| 1 |
38 |
Retirement guestbook,
c.2008
|
| |
Family Correspondence,
1933-1995 [subseries]:
|
| 1 |
39 |
From Robert to his family,
1933
|
| 1 |
40 |
From Robert to Beth Chanock,
1948-1955
|
| 1 |
41 |
Notes,
c.1950s
|
| 1 |
42 |
Well wishes on pericarditis,
1967
|
| 2 |
1 |
Family and friends,
1968-1995
|
| 2 |
2 |
Congratulations on birth of grandson,
1983
|
| 2 |
3 |
Chanock, Foster Osgood,
1975-1980
|
| 2 |
4 |
Chanock, Frances E.,
1995
|
| 2 |
5 |
Chanock, Stephen J.,
1971-1989
|
| |
Awards and Honors,
1945-2008 [subseries]:
|
| 2 |
6 |
Various certificates,
1945-2008
|
| 2 |
7 |
E. Mead Johnson Award for Research in Pediatrics - congratulations and correspondence,
27 October 1964
|
| 2 |
8 |
Kimble Methodology Award - letters of congratulations and correspondence,
31 October 1966
|
| 2 |
9 |
Infectious Diseases Society of America Squibb Award - congratulations, correspondence, and acceptance speech,
25 October 1969
|
| 2 |
10 |
DHEW Distinguished Service Medal - correspondence, photographs, and ceremony program,
15 April 1971
|
| 2 |
11 |
Gorgas Medal - announcement and clipping,
11 December 1972
|
| 2 |
12 |
Election to National Academy of Sciences - letters of congratulations,
1973
|
| 2 |
13 |
Howard Taylor Ricketts Award - announcement, congratulations, event program, lecture transcript,
14 May 1973
|
| 2 |
14 |
Award for Distinguished Achievement - announcement,
1976
|
| 2 |
15 |
University of Chicago - honorary doctorate - announcement, photographs, and convocation program,
14 November 1977
|
| 2 |
16-17 |
Robert Koch Stiftung Award - correspondence, letters of congratulations, ceremony program, photographs, lecture transcript,
7 December 1981
|
| 2 |
18-23 |
ICN International Prize in Virology - announcement, correspondence, letters of congratulations, ceremony program, photographs,
7 February 1991
|
| 2 |
24 |
Presidential Meritorious Executive Rank Award,
1993
|
| 2 |
25-26 |
Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research - announcement, letters of congratulations, ceremony program, and clippings,
7 December 1993
|
| 2 |
27 |
Albert B. Sabin Gold Medal Award - letters of congratulations, ceremony program, lecture transcript, and clippings,
14 September 1995
|
| 2 |
28 |
American College of Physicians Award for Outstanding Work in Science as Related to Medicine - correspondence,
May 2008
|
| |
Photographs,
c.1950s-2005 [subseries]:
|
| 2 |
29 |
Aboard the 'Independence',
c.1950s
|
| 2 |
30 |
Dr. Chanock's friends and colleagues,
c.1960s-2000s
|
| 2 |
31-33 |
Dr. Chanock - with family, in groups, in PHS uniform, at conferences, in laboratory,
1988-1998, undated
|
| 2 |
34 |
A celebration of the career of Dr. Robert M. Chanock, Laboratory of Infectious Diseases, NIAID, NIH,
21 October 2005
|
| |
Clippings,
1954-2008 [subseries]:
|
| 2 |
35-37 |
General,
1958-2008
|
| 3 |
1 |
Obituaries of colleagues,
1995-1998
|
| 3 |
2 |
re Influenza,
1947-1998
|
| 3 |
3 |
Virus discoveries,
1954-1980
|
| Born Digital |
|
Archive-It web archive, top results for "Robert Chanock" Google search conducted by HMD staff, 2018
[view online]
|
| |
Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID),
1955-2008 [series]:
|
| 3 |
4-14 |
NIAID Annual Reports,
1967-1972
|
| 4 |
1-14 |
NIAID Annual Reports (cont'd),
1973-1980
|
| 5 |
1-5 |
NIAID Annual Reports (cont'd),
1980-1983
|
| 5 |
6-13 |
LID Board of Scientific Counselors Review,
1978, 1981, 1984, 1987, 1992, 1996
|
| 6 |
1-11 |
LID Board of Scientific Counselors Review (cont'd),
1996, 2000, 2003, 2004
|
| 6 |
12-23 |
LID Annual Reports [3.5 computer disks],
1966-1970; 1972-1973, 1976, 1982, 1984, 1985, 1987
|
| 7 |
1-14 |
LID Annual Reports (cont'd),
1987-1996
|
| 8 |
1-2 |
LID Annual Reports (cont'd),
1996-1997
|
| 8 |
3-35 |
Calendar - Dr. Chanock's,
1971-2006
|
| |
Correspondence,
1955-2008 [subseries]:
|
| 8 |
36-50 |
Alphabetical by correspondent - A-H,
1957-1968
|
| 9 |
1-19 |
Alphabetical by correspondent - H-W,
1957-1968
|
| 9 |
20-25 |
Alphabetical by correspondent - A-L,
1969-1975
|
| 10 |
1-6 |
Alphabetical by correspondent - M-Z,
1969-1975
|
| 10 |
7-24 |
Alphabetical by correspondent - A-T,
1975-1996
|
| 10 |
25-27 |
Alphabetical by correspondent - A-Z,
1978-1979
|
| 10 |
28 |
Becker, Walter B.,
1963-1971
|
| 10 |
29 |
Brown, Fred,
1989-1992
|
| 10 |
30 |
Children's Hospital, Philadelphia - Dr. Lief,
1964-1966
|
| 10 |
31 |
Croup agent,
1955-1958
|
| 10 |
32 |
Fenner, Frank,
1978-1997
|
| 10 |
33 |
Roizman, Bernard,
1974-1988
|
| 10 |
34 |
Siim, J. Christian,
1979-1991
|
| 10 |
35 |
Stuart-Harris, Charles,
1977-1983
|
| 10 |
36 |
Syrucek, Lubomir,
1965-1972
|
| 10 |
37 |
Walter Reed Army Medical Center,
1962-1969
|
| 10 |
38 |
Wyeth Laboratories,
1964-1969
|
| 10 |
39-41 |
Chronological Files,
1968, 1971-1972
|
| 11 |
1-21 |
Chronological Files,
1973-1981, 1984-1986, 1989-1993, 1995
|
| 11 |
22-44 |
Chronological miscellaneous correspondence,
undated, 1957-1980
|
| 12 |
1-28 |
Chronological miscellaneous correspondence (cont'd),
1981-2008
|
| |
Correspondence of Harry Greenberg and Anthony Kalica,
1976-1983 [subseries]:
|
| 12 |
29 |
Greenberg, Harry correspondence - A-Z by correspondent name,
1976-1983
|
| 12 |
30 |
Kalica, Anthony correspondence - A-Z by correspondent name,
1976-1982
|
| 13 |
1 |
Kalica, Anthony correspondence - A-Z by correspondent name (cont'd),
1976-1982
|
| |
Subjects,
1955-2007 [subseries]:
|
| 13 |
2-5 |
1918 Flu 2005 Avian Flu,
2002-2006
|
| 13 |
6 |
4 New Breast Cancer Genes / DNA Variations for 7 Diseases,
2007
|
| 13 |
7-8 |
Acambis,
1999-2007
|
| 13 |
9 |
Adenovirus and AAV,
1964-2001
|
| 13 |
10 |
Adjuvants for influenza virus vaccines, including use for H5N1 if needed,
2006
|
| 13 |
11 |
Agracetus [photocopy of 1947 article],
undated
|
| 13 |
12-13 |
Albert B. Sabin Vaccine Foundation, Inc.,
1991-1994
|
| 13 |
14-15 |
Anthrax,
1999-2004
|
| 13 |
16 |
Anthrax incidents, hoaxes and threats,
1999
|
| 13 |
17 |
Armed Forces Epidemiological Board (AFEB) - 50th year anniversary,
28 June 1990
|
| 13 |
18-19 |
AFEB Commission on Acute Respiratory Diseases - annual reports,
1969, 2001
|
| 13 |
20 |
AFEB Commission on Influenza - annual report,
1971
|
| 13 |
21 |
Australian National University - annual reports,
1961-1967
|
| 13 |
22-23 |
Avian flu,
2002-2007
|
| 13 |
24 |
Biodefense NIAID,
2002
|
| 13 |
25 |
Bioshield 5105,
2005
|
| 13 |
26 |
Bioterrorist activities - Peter Jahrling, Ph.D. [35mm slides],
29 January 1999
|
| 13 |
27 |
Biowarfare,
1988-1994
|
| 13 |
28 |
Byrne, Robert J., D.V.M. - Deputy Director, Experimental Applications Branch, NIAID,
1979-1980
|
| 13 |
29 |
Chiefs of NIAID [photographs],
2001
|
| 14 |
1 |
Choppin, Purnell,
c.1985
|
| 14 |
2 |
Cold Spring Harbor correspondence,
1986
|
| 14 |
3 |
Conflict of interest issues,
2005
|
| 14 |
4 |
Consultancies - Molecular Vaccines, Inc., and Medimmune,
1988-2002
|
| 14 |
5 |
Dangers of mutants,
1977
|
| 14 |
6 |
Dengue - Jo Blaney,
28 November 2007
|
| 14 |
7 |
Dengue vaccine,
c.1989
|
| 14 |
8 |
Inter-Divisional Vaccine Working Group,
17 September 1993
|
| 14 |
9 |
Edelman memos and correspondence,
1976-1988
|
| 14 |
10 |
Ethics - L.A. Times,
September-October 2004
|
| 14 |
11 |
Executive office NIAID,
1985-1988
|
| 14 |
12 |
Fauci, Dr. Anthony - Director NIAID,
1985-1987
|
| 14 |
13-15 |
Food and Drug Administration (FDA) - Panel on Review of Viral Vaccines and Rickettsial Vaccines,
1975
|
| 14 |
16 |
Freezer repository - inventory contents,
1992
|
| 14 |
17 |
Gallin, Dr. John - Director, Intramural Research Program, NIAID,
1985-1988
|
| |
Goldberg II [subseries]:
Articles sent to Dr. Chanock by journalist Billie Goldberg organized thematically.
|
| 14 |
18 |
Antivirals,
2005
|
| 14 |
19 |
Cancer,
2005
|
| 14 |
20 |
Dengue,
2005
|
| 14 |
21 |
DNA vaccines,
2005
|
| 14 |
22 |
Ebola and Marburg vaccines,
2005
|
| 14 |
23 |
HIV SIV,
2005
|
| 14 |
24 |
Human melanoma virus,
2005
|
| 14 |
25 |
Immunology,
2005
|
| 14 |
26 |
Nobel,
2005
|
| 14 |
27 |
RNAi,
2005
|
| 14 |
28 |
Shingles,
2005
|
| 14 |
29 |
Aviflu,
2006
|
| 14 |
30 |
Biodefense tick borne encephalitis virus,
2006
|
| 14 |
31 |
HIV vaccine,
2006
|
| 14 |
32 |
Important role of inflammation in cardiovascular disease,
2006
|
| 14 |
33 |
Kaposi sarcoma virus receptor,
2006
|
| 14 |
34 |
Old viruses resurrected inhuman DNA,
2006
|
| 14 |
35 |
Osteoporosis protein diabetes genes,
2006
|
| 14 |
36 |
Polio-Weimmer,
2006
|
| 14 |
37 |
Prostate cancer Rx therapy,
2006
|
| 14 |
38 |
RNAi clinical,
2006
|
| 14 |
39 |
Max Theiler 1951,
2006
|
| 14 |
40 |
Vertex HCV,
2006
|
| 14 |
41 |
Vioxx Merck,
2006
|
| 14 |
42 |
West Nile transplant patients,
2006
|
| 14 |
43-44 |
Hartley, Janet,
1981-1994
|
| 14 |
45 |
House hearings on influenza vaccine,
August 1972
|
| 14 |
46 |
Huebner, Robert,
1969-2002
|
| 15 |
1 |
Huebner, Robert (cont'd),
1969-2002
|
| 15 |
2 |
Huebner celebration,
11 November 1999
|
| 15 |
3 |
Hybridon - contract and approval,
1994-1996
|
| 15 |
4 |
ICN Pharmaceuticals,
1990-1991
|
| 15 |
5 |
Infectious Disease Society of America,
1990
|
| 15 |
6 |
Infu H5N1 DOD/NIAID,
2006-2007
|
| 15 |
7 |
Interpretation of serologic reactions in virology - DHEW,
c.1965
|
| 15 |
8-9 |
Intracel,
2000-2001
|
| 15 |
10 |
Intramural Research Program,
1985-1987
|
| 15 |
11 |
Johns Hopkins Society of Scholars,
1999
|
| 15 |
12 |
Kapikian, Albert Z. [photographs],
1984
|
| 15 |
13 |
Krause, Richard M. - Director, NIAID,
1979-1981
|
| 15 |
14 |
Krause, Richard M. (cont'd),
24 March 1995
|
| 15 |
15 |
Laboratory methods in the diagnosis of viral exanthems - DHEW,
c.1965
|
| 15 |
16 |
Laboratory of Viral Diseases - annual report,
1969
|
| 15 |
17 |
Laboratory of Infectious Diseases - history [35mm slides],
1992
|
| 15 |
18 |
Laboratory techniques in virology - DHEW,
c.1965
|
| 15 |
19 |
Mattheis, Martha - Infectious Disease Branch,
1979-1984
|
| |
MedImmune [subseries]:
|
| 15 |
20 |
General,
1998-2005
|
| 15 |
21-25 |
General (cont'd),
1998-2005
|
| 15 |
26 |
Adverse publicity,
1998
|
| 15 |
27 |
Biological materials license agreement,
1996
|
| 15 |
28-38 |
Meetings,
1989-2002
|
| 16 |
1-4 |
Meetings (cont'd),
1989-2002
|
| 16 |
5 |
Sales of Synagis,
January-March 2000
|
| 16 |
6 |
Molecular Vaccines, Inc.,
1988-1989
|
| 16 |
7 |
Monoclonal abs, RSV and otherwise,
1990-1994
|
| 16 |
8-14 |
Morris, Anthony,
1973-1978
|
| 16 |
15-16 |
Mycoplasma pneumonia and others,
1961-2002
|
| 16 |
17-27 |
National Academy of Sciences - Committee on International Security and Arms Control (CISAC),
1988-1997
|
| 17 |
1-8 |
National Academy of Sciences - Committee on International Security and Arms Control (CISAC) (cont'd),
1988-1997
|
| 17 |
9 |
National Academy of Sciences - Sabin, memoirs Rowe,
1998
|
| 17 |
10 |
National Cancer Institute - Frederick Cancer Research Facility Advisory Committee - meeting,
13 February 1987
|
| 17 |
11 |
NIAID Animal Care Committee,
1973-1980
|
| 17 |
12 |
NIAID Biodefense Research Agenda for Category B and C Priority Pathogens - progress report,
2004
|
| 17 |
13-14 |
NIAID Blue Ribbon Panel on Terrorism and its Implications for Biomedical Research,
2002
|
| 17 |
15-16 |
NIAID Clinical Research Subpanel,
1969-1980
|
| 18 |
1 |
NIAID Clinical Research Subpanel (cont'd)
|
| 18 |
2 |
NIAID Committee for Vaccine Development - correspondence,
1962-1967
|
| 18 |
3 |
NIAID Extramural Activities - report,
1968
|
| 18 |
4-6 |
NIAID Intramural Research Program - reports,
1968-1972
|
| 18 |
7 |
NIAID Laboratory Chiefs - meeting minutes,
2002-2005
|
| 18 |
8 |
NIAID Laboratory of Biology of Viruses - annual report,
1968
|
| 18 |
9 |
New York City Department of Health - laboratory analysis of 1957-1958 influenza outbreak in New York City,
1959
|
| 18 |
10-11 |
Pandemic avian flu - Secretary Leavitto's response for greater vaccine production from pharmaceutical manufacturers,
2006
|
| 18 |
12 |
Pandemic flu preparedness,
2001
|
| 18 |
13 |
Papilloma viruses,
c.2000
|
| 18 |
14-15 |
Parainfluenza virus,
1998
|
| 18 |
16 |
Parainfluenza virus / glioma,
2004-2005
|
| 18 |
17 |
Pletnev 5 yr plan,
2004
|
| 18 |
18 |
Pneumonia,
1979
|
| 18 |
19 |
RSV and PIV3 high risk persons: RSV LID,
1991-1992
|
| 18 |
20-21 |
RSV pathogenesis acute and COPD (II),
1993
|
| 18 |
22-26 |
Rowe and Huebner [photographs],
1982-1998
|
| 18 |
27 |
Royal Danish academy of Sciences and letters - elected as foreign member,
1980
|
| 18 |
28-29 |
Russian TBEV collaboration,
2002
|
| 18 |
30-33 |
Sabin, Dr. Albert [photographs],
1964-2006
|
| 19 |
1-7 |
Sabin, Dr. Albert (cont'd),
1964-2006
|
| 19 |
8 |
Sabin poliovaccine [35mm slides],
c.1986
|
| 19 |
9 |
Sabin poliovirus vaccine clinical field trials - final report,
1961
|
| 19 |
10 |
Sabin/Schlesinger dengue,
2003
|
| 19 |
11 |
Scripps Research Institute,
1987-1996
|
| 19 |
12 |
Seasonal and pandemic influenza,
2007
|
| 19 |
13 |
Sell, Kenneth W. - Scientific Director, NIAID,
1978-1984
|
| 19 |
14 |
Small pox,
2001-2006
|
| 19 |
15 |
Smorodintsev adenovirus vaccine,
1969
|
| 19 |
16 |
Society for Pediatric Research,
1993
|
| 19 |
17 |
Sugata, Fumihiko,
1993
|
| 19 |
18 |
Synagis,
1999-2001
|
| 19 |
19 |
Synergistic effect when two disparate mabs are used,
2002-2006
|
| 19 |
20 |
Tyrrell, D. A., Jr.,
1970-1991
|
| 19 |
21 |
U.S. Public Health Service - technical report on Salk poliomyelitis vaccine,
1955
|
| 19 |
22 |
University of British Columbia, Dept. of Microbiology, Div. of Medical Microbiology - annual report,
1971
|
| 19 |
23 |
University of Maryland - prison studies hearing,
3 September 1975
|
| |
Vaccine,
1958-2006 [subseries]:
|
| 19 |
24 |
Adenovirus vaccine program - business case analysis,
c.2006
|
| 19 |
25 |
Vaccine development at the Laboratory of Infectious Diseases,
c.2000
|
| 19 |
26 |
Current status of vaccines for prevention of respiratory syncytial virus infection in infants and children - Peter Wright,
2003
|
| 19 |
27 |
Licensed viral vaccines (U.S.A.),
1988
|
| 19 |
28-29 |
Rotavirus vaccines,
2000-2006
|
| 19 |
30 |
Virology Section - report,
1970
|
| 19 |
31 |
West Nile and Dengue,
2003
|
| 19 |
32 |
World Health Organization (WHO) - viral disease reports,
1958-1971
|
| 19 |
33 |
WHO Expert Advisory Panel on Virus Diseases,
1997
|
| |
Presentations on 35mm Slides,
1961-2005 [subseries]:
|
| 19 |
34 |
Influenza Dearborn TS1[E],
undated
|
| 19 |
35 |
Influenza TS1,
undated
|
| 19 |
36-40 |
Mycoplasma,
undated
|
| 20 |
1-2 |
PI Mpn epidem.,
undated
|
| 20 |
3 |
Poly IC study Knopp,
undated
|
| 20 |
4 |
Respiratory Syncitial,
undated
|
| 20 |
5 |
Respiratory Syncitial Coates,
undated
|
| 20 |
6 |
Smith and Chanock Eaton vol,
undated
|
| 20 |
7 |
Mycoplasma,
1961
|
| 20 |
8 |
Pneumonia,
1961
|
| 20 |
9 |
Respiratory Syncytial Mpn,
1961
|
| 20 |
10 |
Adeno caps PI,
1964
|
| 20 |
11-12 |
Mycoplasma,
c.1965
|
| 20 |
13 |
Respiratory Syncytial and Para,
c.1966
|
| 20 |
14 |
IOM priorities and Respiratory Syncytial Virus,
1966
|
| 20 |
15 |
Mycoplasma,
c.1967
|
| 20 |
16 |
Mycoplasma Boston,
1967
|
| 20 |
17 |
Importance viruses and Mpn respiratory disease,
1968
|
| 20 |
18 |
Respiratory Syncytial temperature sensitive,
1968
|
| 20 |
19 |
Mycoplasma,
1969
|
| 20 |
20 |
Mycoplasma pneumoniae ASM,
1970
|
| 20 |
21 |
Mycoplasma, pneumonia, pap,
1970
|
| 20 |
22 |
PAHO,
December 1970
|
| 20 |
23 |
Flu (temperature sensitive),
1971
|
| 20 |
24 |
Mycoplasma,
1971
|
| 20 |
25 |
Respiratory Syncytial Virus,
1971
|
| 20 |
26 |
Mycoplasma NY Acad.,
January 1973
|
| 20 |
27 |
Respiratory Syncytial,
1973
|
| 20 |
28 |
Animal rights,
c.1979
|
| 20 |
29 |
Rotavirus, dengue, vaccines, etc.,
1980-1981
|
| 20 |
30 |
Long-term goals and strategy of LID research / Sabin polio vaccine,
1986-1988
|
| 20 |
31 |
RSV, dengue, etc.,
c.1989
|
| 20 |
32 |
Respiratory Syncytial,
1989
|
| 20 |
33 |
Respiratory Syncytial Virus chimps and Respiratory Syncytial Virus summaries,
1990
|
| 20 |
34 |
Respiratory Syncytial Virus vaccines,
1990
|
| 20 |
35 |
Rotavirus,
1990
|
| 20 |
36 |
Respiratory Syncytial Virus mabs and fabs,
1990-1995
|
| 20 |
37 |
Respiratory Syncytial Virus,
1991
|
| 20 |
38 |
Respiratory Syncytial Virus,
1992-1993
|
| 20 |
39 |
Respiratory Syncytial Virus (cont'd),
1992-1993
|
| 20 |
40 |
St. Lucia - history of respiratory,
December 2000
|
| 20 |
41 |
Parainfluenza viruses as vectors for the protective antigens of RSV and other respiratory viral antigens,
2004
|
| 20 |
42 |
Reverse genetic studies of the HMPV glycoproteins; Coronavirus vaccines; Respiratory syncytial virus vaccine development,
2005
|
| |
Series 3: Lab Research,
1951-2008 [series]:
|
| |
Lab Notebooks by researcher,
1958-2000 [subseries]:
|
| 21 |
1-2 |
Abinanti, Francis R.,
1958-1964
|
| 21 |
3-19 |
Chanock, Robert M.,
1958-2000
|
| 22 |
1-19 |
Chanock, Robert M. (cont'd),
1958-2000
|
| 23 |
1-19 |
Chanock, Robert M. (cont'd),
1958-2000
|
| 24 |
1-4 |
Chanock, Robert M. (cont'd),
1958-2000
|
| 24 |
5-8 |
Cook, M. Katherine,
1960-1975
|
| 24 |
9 |
Dans, Peter E.,
1966-1967
|
| 24 |
10 |
Forsyth, Ben R.,
1965-1966
|
| 24 |
11-18 |
Hoggan, M. David,
1972-1985
|
| 24 |
19 |
Johnson, Karl M.,
1959-1962
|
| 25 |
1-3 |
Johnson, Karl M. (cont'd),
1959-1962
|
| 25 |
4-8 |
Kapikian, Albert Z.,
1977-1981
|
| 25 |
9-10 |
Lewis, Marianne,
1972-1984
|
| 25 |
11-17 |
Mufson, Maurice A.,
1962-1965
|
| 25 |
18-19 |
Rowe, Wallace P.,
1958-1972
|
| 26 |
1-19 |
Rowe, Wallace P. (cont'd),
1958-1972
|
| 27 |
1-16 |
Rowe, Wallace P. (cont'd),
1958-1972
|
| |
Lab Notebooks by Subject,
1954-1994 [subseries]:
|
| 27 |
17 |
CF Antigens,
1954-1975
|
| 27 |
18 |
Miscellaneous Virus,
1957
|
| 27 |
19 |
Neuraminidase,
1974-1993
|
| 28 |
1-8 |
Neuraminidase (cont'd),
1974-1993
|
| 28 |
9 |
Radioactive Materials,
1971-1974
|
| 28 |
10-16 |
Viral Reagents,
1962-1994
|
| |
Research Data,
1950-2008 [subseries]:
|
| 28 |
17-19 |
Miscellaneous/Unidentified Studies,
undated
|
| 29 |
1-7 |
Miscellaneous/Unidentified Studies (cont'd),
1950-2005
|
| 29 |
8 |
Japanese B encephalitis,
1951-1954
|
| 29 |
9 |
Lab studies on adenovirus, pneumonia or bronchiolites,
1952-1956
|
| 29 |
10 |
Avian Japanese B encephalitis,
1953-1955
|
| 29 |
11 |
Transplacental transmission polio virus,
1954-1955
|
| 29 |
12 |
Polio chick embryo,
1955
|
| 29 |
13 |
Yale - Monkey kidney trypsinization techniques Ph colon test,
1955-1956
|
| 29 |
14 |
Experiment 2. Assay of a high titer phage stock relation of plaque count to volume of phage suspension plated,
1956
|
| 29 |
15 |
Etiology of nonbacterial respiratory disease in infancy and childhood - NIH senior fellowship grant,
1956
|
| 29 |
16 |
Serology,
1956-1957
|
| 69 |
9 |
1 RSV collation,
1956-1957 [RESTRICTED PHI POLICY]
|
| 29 |
17 |
Croup,
1956-1959
|
| 29 |
18 |
Pap virus,
1958-1959
|
| 69 |
11 |
Mycoplasma - U.S. Naval Hospital, Beaufort, S.C. - patient summaries,
1959-1960 [RESTRICTED PHI POLICY]
|
| 29 |
19 |
Respiratory viruses and mycoplasmas clinical: Pap study - Parris Island,
1959-1961
|
| 29 |
20 |
#2 neutralization tests #19,
1959-1998
|
| 29 |
21 |
Immunization,
1961-1962
|
| 69 |
14-15 |
RS vaccine study,
1962-1975 [RESTRICTED PHI POLICY]
|
| 29 |
22 |
Contribution of adenoviruses to respiratory tract illness among children,
1963
|
| 29 |
23 |
Evaluation of WI-26 human diploid fibroblast cultures for isolation of adenovirus type 4,
1963
|
| 29 |
24-25 |
Lots of vaccine - Wyeth,
1963-1968
|
| 29 |
26-27 |
Mycoplasma,
1963-1992
|
| 29 |
28 |
Ludwig adeno capsule,
1964
|
| 29 |
29 |
Respiratory viruses and mycoplasmas clinical: adeno field trials - Parris Island,
1964-1965
|
| 30 |
1 |
Respiratory viruses and mycoplasmas clinical: m. pneumonia trials - Parris Island,
1965-1966
|
| 30 |
2 |
Respiratory viruses and mycoplasmas clinical: rs attenuated strain - 2,
1965-1970
|
| 69 |
18 |
Children's Hospital contract reports,
1965-1981 [RESTRICTED PHI POLICY]
|
| 30 |
3 |
Drug protocols - Wyeth,
1966
|
| 30 |
4 |
Respir. Viruses and mycoplasmas clinical: adeno field trials other,
1966-1967
|
| 69 |
17 |
RS vaccine study,
1967 [RESTRICTED PHI POLICY]
|
| 30 |
5 |
Experimental rubella vaccine lot 12-6/6A,
1967
|
| 30 |
6 |
Myxovirus recovery from respiratory tract illness - summary tables,
1967
|
| 30 |
7 |
Camargo, Ena - RSV - paraflu III plaque,
1967-1972
|
| 30 |
8-13 |
RS vaccine - Children's Hospital of D.C.,
1967-1979
|
| 30 |
14-16 |
Production protocol - adenovirus vaccine, life, oral - type 7 - Wyeth,
1968-69
|
| 30 |
20 |
RS #3 challenge of para 1 new,
November 1970
|
| 30 |
17 |
RS ts 1 mutant - Jessup,
30 December 1969
|
| 30 |
18 |
Clinical research protocols,
1969-1978
|
| 30 |
19 |
RS volunteer - wild type challenge of ts1 vaccinees,
13 February 1970
|
| 30 |
21 |
DBS-IND-294 Wyeth, adenovirus vaccine, type 7, live, oral - book 2,
1970-1972
|
| 30 |
22 |
Antibody response to m. pneumoniae vaccine,
1971
|
| 30 |
23 |
RSV clinical summary - Children's Hospital,
1971
|
| 30 |
24 |
Virus-associated immunopathology animal models and implications for human diseases,
c.1972
|
| 30 |
25 |
RSV primates: to RS in children,
c.1972-1973
|
| 69 |
23 |
Children's Hospital - nasal washings,
1972-1974 [RESTRICTED PHI POLICY]
|
| 30 |
26 |
Lab reports,
1973
|
| 30 |
27 |
Influenza A/1968 (H3N2) virus serum hemagglutination - inhibition antibody status of children before and after the Nov. 1972-Jan. 1973 epidemic of influenza A/1972 (H3N2) in Washington, D.C.,
1973
|
| 30 |
28 |
Clinical observation of infants/children receiving RS-A2, ts-1 mutant,
1973
|
| 30 |
29 |
Mycoplasma vaccine trial (OSU-1) - Naval Medical Field Research Laboratory,
1974
|
| 30 |
30 |
Safety test protocol - A/Georgia/101/74 clone 1B,
1974
|
| 30 |
31 |
RS vaccine summaries - Children's Hospital,
1974-1975
|
| 31 |
1 |
RSV primates: bovine RSV in cotton rats, owl monkeys and chimps,
1974-1993
|
| 31 |
2 |
Swine influenza - Burroughs Wellcome Research Labs,
1975-1979
|
| 31 |
3 |
Camargo, Ena - RSV,
1975-1980
|
| 31 |
4 |
Huebner tumorigenicity TS-1-E (Morris),
1976
|
| 31 |
5 |
Status of two dose trials,
1976
|
| 31 |
6 |
Safety test - parainfluenza virus type 3, strain #22311 (lot F-367),
1976
|
| 31 |
7 |
RSV primates: genetic stability - stress tests RS,
1976-1989
|
| 31 |
8 |
Safety test of influ. A/VIC/3/75 (H3N2) x ts-1 [E], clone 81C1, recomb. virus (code CF/PP/1) - Flow Labs,
1977
|
| 31 |
9 |
Lot F-486 - RSV, strain A2, TS-1 NG-16 mutant,
1977-1979
|
| 31 |
10 |
RSV primates II,
1977-1991
|
| 31 |
11 |
Attenuated influenza vaccines,
1981
|
| 31 |
12 |
Nasal washings - Children's Hospital,
1981
|
| 31 |
13 |
RSV hr mutants in primates ts in primates: guinea pig kidney cell grown RSV - pass 18 chimps,
1981
|
| 31 |
14 |
RSV primates: cotton rat RS,
1981
|
| 31 |
15 |
RSV hr mutants in primates ts in primates: chick lung cell grown RSV passage 6 - chimps,
1982
|
| 31 |
16 |
RSV primates,
1982-1993
|
| 31 |
17 |
Research labs - Merck Sharp and Dohme,
1983-1991
|
| 31 |
18 |
SV40,
1983-2001
|
| 31 |
19-20 |
Production protocols - Wyeth,
1985
|
| 31 |
21 |
RSV hr mutants in primates ts in primates: primates studies RSV,
1986-1990
|
| 31 |
22 |
Immunization: flavi and alpha viruses,
1988
|
| 31 |
23 |
Prophylactic effect antibodies,
18 October 1988
|
| 31 |
24 |
MF59 Chiron,
1989-2006
|
| 31 |
25 |
RSV vaccine testing,
1989-2006
|
| 31 |
26 |
Fourth NIH rotavirus vaccine workshop,
5-6 November 1990
|
| 31 |
27 |
RSV ICN Krugman,
1991-1993
|
| 31 |
28 |
Flavivirus vaccine research - Walter Reed-NIAID,
1991-1994
|
| 31 |
29-30 |
RSV human fob monoclones,
December 1991-February 1995
|
| 31 |
31 |
CA influenza virus - Wyeth,
1992-1993
|
| 31 |
32 |
RSV - Repligen,
1993
|
| 31 |
33 |
Fab 19 MARM,
1993-1995
|
| 31 |
34 |
RSV human FABS,
5 February 1995
|
| 31 |
35-36 |
AGMK cells, karyotype, tumor tests, patent,
1994-2000
|
| 32 |
1-3 |
Bovine RV (4x) clinical trial,
1997
|
| 32 |
4 |
U.S.-Russian collaboration final report,
1997
|
| 32 |
5-7 |
TBEV LGT,
1998-2000
|
| 32 |
8-9 |
TBEV II and West Nile,
2000
|
| 32 |
10 |
History of discovery and development of successful interventions,
2000
|
| 32 |
11 |
West Nile virus,
2000-2006
|
| 32 |
12 |
Periodic dengue, West Nile, TBEV meetings,
2001
|
| 32 |
13-14 |
Dengue vaccine part II,
2001-2007
|
| 33 |
13 |
Dengue virus and West Nile virus,
2008
|
| 32 |
15 |
Dengue virus vaccine development,
2002
|
| 33 |
1 |
TBEV and Langat II,
2002
|
| 33 |
2 |
Dengue virus vaccine data,
2003
|
| 33 |
3 |
Restoration of live adenoviruses vaccine in DOD,
2003-2005
|
| 33 |
4-6 |
Negative SV40,
2004
|
| 33 |
7-8 |
Positive SV40,
2004
|
| 33 |
9 |
Dengue virus vaccine development,
2004
|
| 33 |
10 |
Clinical WN/Den4 serology immunogenicity - clinical Lat/Den4 serology immunogenicity,
2005
|
| 33 |
11 |
Dengue candidates,
August 2006
|
| 33 |
12 |
Den langat,
2006
|
| |
LID Lab Research Reports,
1960-2004 [subseries]:
|
| 33 |
14-27 |
Clinical research projects,
1960-1982
|
| 33 |
28 |
NIAID ad hoc contract review,
1973
|
| 33 |
29 |
Experimental immunoprophylaxis against respiratory syncytial virus infections in primates,
undated
|
| 33 |
30 |
Experimental infection of primates with respiratory syncytial virus,
undated
|
| 33 |
31 |
Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus,
undated
|
| 33 |
32 |
Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants,
undated
|
| 33 |
33 |
RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research,
1968
|
| 33 |
34 |
Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections,
1969
|
| 33 |
35 |
Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age,
1969
|
| 33 |
36 |
Serum complement in acute bronchiolitis,
1969
|
| 33 |
37 |
Pediatric adenovirus vaccine evaluations,
1971
|
| 33 |
38 |
Fort Detrick reports,
1972-1977
|
| 34 |
1 |
Chanock scientific studies,
1973-1992
|
| 34 |
2 |
Transferring viruses to NIAID,
1997-1998
|
| 34 |
3 |
Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section,
c.2000
|
| 34 |
4-5 |
Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section,
2000-2001
|
| 34 |
6 |
Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers,
2001
|
| 34 |
7 |
Projected schedule for WNV/DEN4 chimera studies,
2001
|
| 34 |
8 |
New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus,
2003
|
| 34 |
9 |
The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section,
2004
|
| 34 |
10 |
In vitro models of paramyxovirus infection,
2004
|
| 34 |
11 |
New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section,
2004
|
| 34 |
12 |
NIAID 69-A - Study of non-bacterial respiratory disease A) children,
1966-1969
|
| 34 |
13 |
NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis,
1966
|
| 34 |
14 |
NIAID 69-C - The etiology of acute respiratory disease in civilian adults,
1965
|
| 34 |
15 |
NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines,
1966
|
| 34 |
16 |
NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness,
1966
|
| 34 |
17 |
NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin,
1966
|
| 34 |
18 |
NIAID 70-C - Basic studies on mycoplasma,
1966
|
| 34 |
19 |
NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO),
1966
|
| 34 |
20 |
NIAID 70-D - Laboratory studies of viral hepatitis agents,
1966
|
| 34 |
21 |
NIAID 70-E - Biological and biophysical studies of rhinoviruses,
1966-1969
|
| 34 |
22 |
NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers,
1969
|
| |
Investigational New Drugs (IND),
1963-2001 [subseries]:
|
| 34 |
23 |
Unnumbered - Attenuated quadrivalent human-bovine (UK) rotavirus reassortant vaccine - original submission,
1995
|
| 34 |
24 |
Unnumbered - Wild-type and attenuated respiratory syncytial viruses; subgroup B,
1993
|
| 34 |
25 |
IND #24 - Parainfluenza type 3 vaccine - suppl. 1-4,
1963-1967
|
| 34 |
26-31 |
IND #71 - Live adenovirus type 4 enteric vaccine - suppl. 31-50,
1967-1972
|
| 34 |
32-35 |
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24,
1964-1973
|
| 35 |
1-2 |
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24 (cont'd),
1964-1973
|
| 35 |
3 |
IND #385 - Monovalent adenovirus type 2 soluble antigen vaccine, aqueous or alum absorbed - suppl. 1, 4-6,
1969-1971
|
| 35 |
4 |
IND #386 - Live, attenuated rubella virus vaccine strain HPV-79-RK 7, lot 31764 - suppl. 2-3,
1969
|
| 35 |
5 |
IND #401 - Meningococcal group C vaccine - suppl. 1-36,
1969-1973
|
| 35 |
6-7 |
IND #419 - Complexed polyinosinic and polycytidylic acids - suppl. 1-13,
1969-1970
|
| 35 |
8-9 |
IND #421 - Parainfluenza 3 challenge pool (attenuated?) - suppl. 1-23,
1969-1973
|
| 35 |
10 |
IND #437 - Pneumococcal polysaccharide vaccines,
1970-1972
|
| 35 |
11 |
IND #450 - Vaccinia virus vaccine -suppl. 7,
1971
|
| 35 |
12 |
IND #582 - H. Influenzae type b PRP vaccine - suppl. 10, 188,
1972-1987
|
| 35 |
13-20 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399,
1972-1995
|
| 36 |
1-17 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 37 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 38 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 39 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 40 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 41 |
1-3 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 41 |
4-5 |
IND #734 - TS mutants of mycoplasma pneumoniae - suppl. 1-1C (inactive),
1974-1977
|
| 41 |
6 |
IND #735 - Inactivated monovalent influenza B virus vaccine,
1973
|
| 41 |
7-8 |
IND #825 - Inactivated influenza A virus vaccines subunit - suppl. 1-30,
1974-1980
|
| 41 |
9 |
IND #839 - Poly I; poly C: poly-l-lysine - suppl. 1,
1974
|
| 41 |
10 |
IND #1044 - Live parainfluenza virus vaccines types 1, 2, and 3, placebo - suppl. 1-8 (inactive),
1975-1978
|
| 41 |
11-19 |
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51,
1976-1980
|
| 42 |
1-6 |
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51 (cont'd),
1976-1980
|
| 42 |
7 |
IND #1287 - Adenovirus subunit vaccines - suppl. 1-11,
1978-1982
|
| 42 |
8-17 |
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118,
1978-1990
|
| 43 |
1-17 |
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118 (cont'd),
1978-1990
|
| 43 |
18 |
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37,
1979-1993
|
| 44 |
1-5 |
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37 (cont'd),
1979-1993
|
| 44 |
6 |
IND #1462 - Varicella virus vaccine - suppl. 123,
1987
|
| 44 |
7-20 |
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139,
1980-1998
|
| 45 |
1-15 |
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139 (cont'd),
1980-1998
|
| 45 |
16 |
IND #1808 - E. coli CFA/II pili vaccine oral - suppl. 4,
1985
|
| 45 |
17 |
IND #1914 - Interferons - suppl. 9-10,
1985
|
| 45 |
18 |
IND #2000 - Vi capsular antigen - suppl. 4,
1985
|
| 45 |
19-21 |
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63,
1988-1995
|
| 46 |
1-7 |
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63 (cont'd),
1988-1995
|
| 46 |
8-10 |
IND #2858 - Bovine parainfluenza virus type 3 - suppl. 1-30,
1988-1994
|
| 46 |
11-14 |
IND #4006 - Rhesus rotavirus vaccines, live, (tetravalent, serotypes 1, 2, 3, and 4) oral - suppl. 1-25,
1988-1998
|
| 46 |
15-19 |
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58,
1993-2000
|
| 47 |
1-5 |
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58 (cont'd),
1993-2000
|
| 47 |
6-9 |
IND #4981 - Respiratory syncytial virus subgroup B (strain 14617, vero 1 cells) wild type and attenuated live vaccines - suppl. 1-33,
1993-2000
|
| 47 |
10 |
IND #7762 - Respiratory syncytial virus, live, attenuated vaccine and purified fusion protein with alum - suppl. 1-6, 8-9,
1998-2001
|
| |
Research Contracts,
1952-2001 [subseries]:
|
| |
Proposals,
1955-2001 [subseries]:
|
| 47 |
11 |
Unidentified,
undated
|
| 47 |
12 |
Etiology of viral diarrheas - part III,
undated
|
| 47 |
13 |
To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg,
1955
|
| 47 |
14 |
Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
c.1964
|
| 47 |
15 |
The isolation of viruses and viral subunits,
1964
|
| 47 |
16 |
Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures,
c.1965
|
| 47 |
17 |
Studies on adenovirus vaccines,
c.1965
|
| 47 |
18 |
Biochemical and immunologic investigations of neisseria meningitidis,
1965
|
| 47 |
19 |
Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae,
1965
|
| 47 |
20 |
To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
1965
|
| 47 |
21 |
Concentration of human hepatitis virus (supplement to NIAID Support of Man program),
1966
|
| 47 |
22 |
Proposed vaccine studies, Kansas City,
1966
|
| 47 |
23 |
Respiratory virus vaccines,
1967
|
| 47 |
24 |
Tests in infants and children for antigenicity and effectiveness of inactivated vaccines,
1967
|
| 47 |
25 |
X-ray crystal structure of adenovirus coat protein,
1969
|
| 47 |
26 |
Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
1971
|
| 47 |
27 |
Studies on hemophilus influenzae b vaccine,
c.1972
|
| 47 |
28 |
Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization,
1974
|
| 47 |
29 |
Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells,
1975
|
| 47 |
30 |
Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection,
1975
|
| 47 |
31 |
Protective efficacy of langat virus vaccines in mice - animal study proposal,
1997
|
| 47 |
32 |
Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal,
1999
|
| 47 |
33 |
Evaluation of chimeric TBEV/DEN4 virus vaccines in mice,
2001
|
| 47 |
34 |
Immunogenicity and protective efficacy of langat virus vaccines in mice,
2001
|
| |
Reports,
1952-1998 [subseries]:
|
| 47 |
35-39 |
National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati,
1952-1956
|
| 47 |
40 |
Vaccine development program commitments,
1965
|
| 47 |
41 |
Respiratory vaccine development,
1966
|
| 47 |
42 |
Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory,
1967
|
| 47 |
43 |
NIAID Molecular Anatomy Program,
1967
|
| 47 |
44 |
Evaluation of a live type 4 adenovirus vaccine,
1967-1968
|
| 47 |
45 |
Acute infectious nonbacterial gastroenteritis,
1973
|
| 47 |
46 |
103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies,
1964-1965
|
| 47 |
47 |
6-61-03-032 - Studies on virus and rickettsial diseases,
1953
|
| 47 |
48 |
263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions,
1981
|
| 47 |
49 |
263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions,
1981
|
| 47 |
50 |
3A014501B71Q - Communicable diseases - immunology,
c.1966
|
| 47 |
51 |
DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines,
1963
|
| 47 |
52 |
DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus,
1965
|
| 47 |
53 |
DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections,
1965
|
| 47 |
54 |
DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus,
1967
|
| 47 |
55 |
DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus,
1971
|
| 47 |
56 |
DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus,
1971
|
| 47 |
57 |
M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits,
1972
|
| 48 |
1 |
NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines,
1970
|
| 48 |
2 |
NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines,
1970
|
| 48 |
3 |
NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1969
|
| 48 |
4 |
NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines,
1971
|
| 48 |
5-6 |
NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
1971, 1973
|
| 48 |
7 |
N01-AI-01528 - New viruses in relation to clinical diseases,
1968-1972
|
| 48 |
8-9 |
N01-AI-02638 - Operation of a virus vaccine production laboratory,
1980-1981, 1983-1987
|
| 48 |
10 |
N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals,
1981
|
| 48 |
11-13 |
N01-AI-05057 - University of Puerto Rico,
1991-1992
|
| 48 |
14-15 |
N01-AI-05067 - Care and housing of AIDS research animals,
1990-1991
|
| 48 |
16 |
N01-AI-17757 - Children's Hospital,
1980-1981
|
| 48 |
17-19 |
N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults,
1972-1989
|
| 48 |
20 |
N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains,
1974
|
| 48 |
21 |
N01-AI-22508 - Clinical evaluation of influenza virus vaccines,
1974
|
| 48 |
22 |
N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . .,
1993-1994
|
| 49 |
1-2 |
N01-AI-32521 - Operation of a virus laboratory in support of LID,
1974-1990
|
| 49 |
3-4 |
N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity,
1978
|
| 49 |
5 |
N01-AI-42528 - Influenza research center,
1979
|
| 49 |
6 |
N01-AI-52565,
1985-1987
|
| 49 |
7-8 |
N01-AI-72535 - Establishment of an infectious enteric disease study,
1978-1979
|
| 49 |
9-10 |
N01-AI-82681 - Operation of an experimental virus vaccine production laboratory,
1988-1989
|
| 49 |
11 |
N01-AO-52703 - Care and housing of AIDS research animals,
1997-1998
|
| 49 |
12 |
N01-AO-52706 - Facility for non-human primates utilized in infectious disease research,
1998
|
| 49 |
13 |
PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture,
1966
|
| 49 |
14 |
PH-43-62-80 - Production of enterovirus antisera,
1965
|
| 49 |
15 |
PH-43-62-127 - Preparation of immune serum to enteroviruses,
1965
|
| 49 |
16 |
PH-43-62-129 - Standardization of picornavirus immune sera,
1965
|
| 49 |
17-26 |
PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine,
1962-1970
|
| 49 |
27-29 |
PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance,
1966-1968
|
| 49 |
30-32 |
PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines,
1966-1968
|
| 49 |
33 |
PH-43-62-839 - Preparation of mycoplasma antigene and antisera,
1965
|
| 49 |
34-35 |
PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children,
1968, 1970
|
| 49 |
36-38 |
PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population,
1966-1968
|
| 50 |
1-4 |
PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species,
1964-1966
|
| 50 |
5-6 |
PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses,
1965, 1967
|
| 50 |
7 |
PH-43-63-81 - Development, growth and characterization of virus induced tumor cells,
1967
|
| 50 |
8 |
PH-43-63-90 - Upper respiratory virus,
1965
|
| 50 |
9 |
PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory,
1966
|
| 50 |
10-11 |
PH-43-63-562 - Prevention of viral respiratory infections,
1964, 1968
|
| 50 |
12 |
PH-43-63-563 - Vaccine studies in a children's center,
1968
|
| 50 |
13 |
PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection,
1967
|
| 50 |
14-16 |
PH-43-63-582 - Respiratory disease vaccine,
1962-1967
|
| 50 |
17-18 |
PH-43-63-1128 - Surveillance of respiratory infections in an industrial population,
1966, 1968
|
| 50 |
19-20 |
PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population,
1967-1968
|
| 50 |
21 |
PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus,
1964
|
| 50 |
22 |
PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses,
1965
|
| 50 |
23 |
PH-43-63-1177 - Reference seeds for echo and coxsackieviruses,
1965
|
| 50 |
24 |
PH-43-64-529 - Preparation and development of viral reagents,
1965
|
| 50 |
25-27 |
PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis,
1966, 1968, 1972
|
| 50 |
28-29 |
PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine,
1966-1967
|
| 50 |
30-32 |
PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs,
1965-1967
|
| 50 |
33-34 |
PH-43-65-562 - Rhinovirus reference laboratory,
1966-1967
|
| 50 |
35-36 |
PH-43-65-563 - Studies of RSV vaccines,
1966-1967
|
| 50 |
37 |
PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents,
1968
|
| 50 |
38-40 |
PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections,
1966-1968
|
| 50 |
41 |
PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers,
1966
|
| 50 |
42-43 |
PH-43-66-93 - Rubella vaccine development,
1967-1968
|
| 50 |
44 |
PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines,
1967
|
| 50 |
45 |
PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines,
1968
|
| 50 |
46-47 |
PH-43-66-461 - Research and development of an inactivated rubella virus vaccine,
1967-1968
|
| 50 |
48 |
PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents,
1966
|
| 50 |
49 |
PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man,
1966-1968
|
| 50 |
50 |
PH-43-66-565 - Development of a live vaccine for human influenza,
1966
|
| 50 |
51-52 |
PH-43-66-917 - The role of infection in precipitating sudden deaths in infants,
1969
|
| 50 |
53-54 |
PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions,
1967-1968
|
| 50 |
55 |
PH-43-66-970 - Operation of a tissue culture developmental laboratory,
1967
|
| 50 |
56 |
PH-43-66-971 - Provide for the operation of a serology laboratory,
1967
|
| 50 |
57-58 |
PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children,
1968, 1970
|
| 50 |
59-60 |
PH-43-67-75 - The testing of rubella virus vaccines in human volunteers,
1967-1968
|
| 50 |
61 |
PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus,
1968
|
| 50 |
62 |
PH-43-67-77 - Biologic and antigenic studies with rubella virus,
1968
|
| 50 |
63 |
PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines,
1968
|
| 50 |
64-65 |
PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines,
1967
|
| 50 |
66 |
PH-43-67-80 - Studies of rubella vaccine efficacy,
1967
|
| 50 |
67 |
PH-43-67-91 - Research and development of respiratory disease vaccines,
1967-1968
|
| 50 |
68 |
PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines,
1973
|
| 50 |
69 |
PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis,
1969
|
| 50 |
70-71 |
PH-43-67-745 - Studies of local antibody in respiratory viral immunity,
1967, 1969
|
| 50 |
72 |
PH-43-68-81 - Operation of a rubella virus service laboratory,
1968
|
| 50 |
73 |
PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein,
1968
|
| 50 |
74 |
PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines,
1968
|
| 51 |
1-4 |
PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses,
1968-1975
|
| 51 |
5-6 |
PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1968-1969
|
| 51 |
7 |
Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus,
1977
|
| 51 |
8 |
Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus,
1978-1981
|
| |
Cooperative Research and Development Agreements (CRADA),
1972-2003 [subseries]:
|
| 51 |
9 |
License agreements,
1988-1996
|
| 51 |
10-11 |
Chiron,
1988-2003
|
| 51 |
12-15 |
Intracel,
1995-1997
|
| 51 |
16-21 |
Lederle,
1992-2000
|
| 52 |
1-10 |
Lederle (cont'd),
1992-2000
|
| 52 |
11 |
MedImmune,
2002
|
| 52 |
12 |
Praxis,
1987-1988
|
| 52 |
13 |
Upjohn,
1988
|
| 52 |
14-27 |
Wyeth,
1972-2001
|
| 53 |
1-5 |
Wyeth (cont'd),
1972-2001
|
| |
Series 4: Patents,
1966-2008 [series]:
|
| 53 |
6-7 |
Chanock's patents,
1967-2000
|
| 53 |
8-10 |
Patent status reports,
2002-2008
|
| 53 |
11 |
Confluent growth of mycoplasma - application,
1966-1967
|
| 53 |
12-15 |
#3,317,393 - Immunization by selective infection of the intestinal tract with an encapsulated live virus,
1967-2005
|
| 53 |
16-17 |
#3,992,522 - Temperature sensitive recombinant mutant viruses and a process for producing same,
1974-1976
|
| 53 |
18 |
#4,552,757 - Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus,
1984-1988
|
| 53 |
19-20 |
#4,571,385 - Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors,
1995-1999
|
| 53 |
21-29 |
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth),
1998-2005
|
| 54 |
1-4 |
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth) (cont'd),
1998-2005
|
| 54 |
5 |
#4,751,080 - Vaccine against rotavirus diseases,
1988
|
| 54 |
6-9 |
#4,800,078 - Immunotherapeutic method of treating respiratory disease by intranasal administration of IGB,
1966-1993
|
| 54 |
10 |
#5,646,033 - African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines,
1997
|
| 54 |
11-18 |
#5,762,905 - Human neutralizing monoclonal antibodies to respiratory syncytial virus,
1995-2004
|
| 54 |
19 |
#5,882,651 - Attenuated respiratory syncytial virus vaccine compositions,
1993
|
| 54 |
20 |
#5,911,998 - Method of producing a virus vaccine from an African green monkey kidney cell line,
1999
|
| 54 |
21 |
#5,922,326 - Attenuated respiratory snycytial virus vaccine compositions,
1993
|
| 54 |
22 |
#6,117,667 - Method for producing an adapted virus population from an African green monkey kidney cell line,
2000
|
| 54 |
23-33 |
#6,184,024 - Chimeric and/or growth restricted flaviviruses,
1992-2007
|
| 55 |
1-2 |
#6,184,024 - Chimeric and/or growth restricted flaviviruses (cont'd),
1992-2007
|
| 55 |
3-9 |
#6,497,884 - Chimeric vaccine against tick-borne encephalitis virus,
2000-2007
|
| 55 |
10 |
#6,660,273 - Chimeric vaccine against tick-borne encephalitis virus,
2003
|
| 55 |
11-12 |
#6,676,936 - Chimeric and/or growth-restricted flaviviruses,
1998-1999
|
| 55 |
13-19 |
#6,794,174 - Full-length infectious cDNA clones of tick-borne flavivirus,
2001-2008
|
| 55 |
20 |
#7,150,984 - Attenuated human rotavirus vaccine,
2006
|
| 55 |
21 |
#7,364,737 - Human neutralizing monoclonal antibodies to respiratory syncytial virus,
2008
|
| 55 |
22-25 |
#7,932,074 - Multivalent human-bovine rotavirus vaccine,
1998-2006
|
| 55 |
26-28 |
#8,778,671 - Construction of West Nile virus and dengue fever chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus,
2001-2004
|
| |
Series 5: Writings/Reprints,
1953-2007 [series]:
|
| 55 |
29 |
Chanock numbered bibliography (1-653),
2003
|
| |
Numbered Articles by Dr. Chanock,
1953-2003 [subseries]:
|
| 55 |
30-34 |
1-5,
1953-1954
|
| 56 |
1-144 |
6-151 [incomplete],
1954-1967
[missing 127, 149]
|
| 57 |
1-148 |
152-323 [incomplete],
1967-1976
[missing 169, 194, 200, 203, 209, 219, 221, 230, 236, 247, 250, 252-253, 257, 259, 290, 291, 293-295, 301, 310, 315, 319]
|
| 58 |
1-194 |
325-568 [incomplete],
1976-1989
[missing 330, 340, 342, 348, 350, 364, 370, 384, 396, 411, 443-444, 449-450, 460, 464-465, 467, 470, 471, 474-477, 479, 481-482, 502-503, 505, 509, 524-525, 527, 532, 534, 537, 540-542, 546, 551-552, 557-558, 560, 563-566]
|
| 59 |
1-46 |
570-653 [incomplete],
1989-2003
[missing 574, 576, 579-581, 584, 586, 589-594, 597-600, 602, 605, 608, 611-612, 615, 618, 620-623, 625, 629-630, 641-644, 647-649]
|
| |
Unnumbered Reprints by Dr. Chanock,
1954-2005 [subseries]:
|
| 59 |
47 |
Respiratory syncytial vaccine - with Murphy, Collins, and Olmsted,
undated
|
| 59 |
48 |
Recovery and characterization of hemagglutinins from two immunologically distinct types of dengue virus - with Sabin and Sweet,
c.1954
|
| 59 |
49 |
III. Production of illness and clinical observations in adult volunteers,
1961
|
| 59 |
50 |
Primary atypical pneumonia,
1966
|
| 59 |
51 |
Genetic approaches to the prevention of influenza A virus infection - with Murphy,
1981
|
| 59 |
52 |
Strain-specific serum antibody response in infants undergoing primary infection with respiratory syncytial virus - with Hendry, Burns, Walsh, Graham, Wright, Hemming, Rodriguez, Kim, Prince, McIntosh, and Murphy,
1988
|
| 59 |
53 |
Antigenic analysis of the dengue virus envelope glycoprotein using synthetic peptides - with Markoff, Bray, Lai, Eckels, Summers, Gentry, Houghten, and Lerner,
1988
|
| 59 |
54 |
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev,
2005
|
| |
Drafts by Dr. Chanock,
c.1960s-c.2007 [subseries]:
|
| 59 |
55 |
Untitled fragments,
undated
|
| 59 |
56 |
Acute respiratory disease of infancy and childhood - present understanding and prospects for prevention,
undated
|
| 59 |
57 |
Blueprint for use of live virus vaccine to prevent a pandemic of influenza A virus - with Murphy and Spring,
undated
|
| 59 |
58 |
Decreased virulence and protective effect of a genetically stable temperature-sensitive mutant of m. pneumoniae in human volunteers,
undated
|
| 59 |
59 |
Infection of immature white mice by the addition of western equine encephalitis virus to the feed,
undated
|
| 59 |
60 |
Parainfluenza, respiratory syncytial, and New Castle disease viruses - with Parrott (title page only),
undated
|
| 59 |
61 |
Development of immunity - outline,
c.1960s
|
| 59 |
62 |
Prospects for control of auto viral mycoplasmal respiratory tract disease by vaccination,
c.1960s
|
| 59 |
63 |
Untitled draft re pediatric respiratory illnesses at Camp Lejeune 1959-1963,
c.1964
|
| 59 |
64 |
The contribution of adenoviruses to respiratory tract illness among children,
c.1965
|
| 59 |
65 |
The relationship of mycoplasma pneumoniae to pediatric respiratory tract disease - with Canchola, Brandt, Kim, and Parrott,
1970
|
| 59 |
66 |
Guide for the collection and transport of virological specimens,
1975
|
| 59 |
67 |
Virus and mycoplasma pneumoniae in respiratory disease patients, January 1975-June 1976 - with Brandt, Kim, Arrobio, and Parrott,
c.1977
|
| 59 |
68 |
Isolation and characterization of temperature-sensitive mutants of influenza A virus,
1977
|
| 59 |
69 |
Bovine respiratory syncytial virus: studies in experimental animals - with Prince, Suffin, Horswood, Camargo, Prevar, and Sly,
1980
|
| 59 |
70 |
Respiratory syncytial virus in cotton rats: growth, antigenicity and protective efficacy of two temperature-sensitive, live virus vaccine candidates, ts-1-NG-1 and ts-1-NG-16 - with Prince, Horswood, Prevar, Camargo, Suffin, and Spring,
1980
|
| 59 |
71 |
HLA antigens in severe respiratory syncytial virus disease in infants and early childhood - with Johnson, Kiim, Hartzman, Parrott, Woody, and Sell,
1981
|
| 59 |
72 |
Studies of avian-human reassortant influenza A viruses in seronegative (HAE<1:8) adult volunteers, 1984-86 - with Clements, Murphy, Snyder, Buckler-White, Tierney, Betts, Dolin, Black, and Sears,
1986
|
| 59 |
73 |
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations,
1991
|
| 59 |
74 |
A live cold-passaged temperature-sensitive mutant of human respiratory syncytial virus is highly attenuated, genetically stable, immunogenic, and efficacious against wild type challenge in seronegative chimpanzees,
1993
|
| 59 |
75 |
"Cold-passaged and temperature sensitive (ts) derivatives of the partially attenuated respiratory syncytial virus ts-4 mutant are more restricted in replication in mice - with Crowe, Jr., Hsu, Lubeck, and Murphy,
c.1994
|
| 59 |
76 |
Short summary of studies of chimeric viruses as candidates for live attenuated vaccine against tick-borne encephalitis,
2000-2005
|
| 59 |
77 |
Comparison of live and inactivated tick-borne encephalitis virus vaccines for immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev,
2005
|
| 59 |
78 |
Early experiences with influenza adjuvated vaccines,
c.2007
|
| |
Untitled Drafts by Dr. Chanock,
c.1955-c.2007 [subseries]:
|
| 59 |
79 |
Miscellaneous individual pages,
undated
|
| 59 |
80 |
The interplay of immunologic factors in acute viral respiratory tract disease,
undated
|
| 59 |
81 |
pages 16-22 re ts mutants,
undated
|
| 59 |
82 |
There is compelling evidence that local immunity plays a major role in resistance to most respiratory viral pathogens,
undated
|
| 59 |
83 |
re temperature-sensitive mutants,
undated
|
| 59 |
84 |
re vaccines against RSV,
undated
|
| 59 |
85 |
re arthropod-borne encephalitis viruses,
c.1955
|
| 59 |
86 |
pages 3-15 re RS virus,
c.1962
|
| 59 |
87 |
report on tests of inactivated respiratory virus vaccines,
c.1967-1968
|
| 59 |
88 |
mycoplasma pneumoniae,
1973
|
| 59 |
89 |
RS virus (RSV) is the major viral pathogen of the respiratory tract,
1975
|
| 59 |
90 |
Respiratory syncytial (RS) virus is the major etiologic agent of bronchiolitis,
1976
|
| 59 |
91 |
pages 25-90 of "f-rot.doc",
1989
|
| 59 |
92 |
Evaluation of antibody response to RSV,
1990
|
| 59 |
93 |
pages 9-29 re serum RSV antibodies,
c.1994
|
| 59 |
94 |
re vaccine against TBEV,
c.2002
|
| 59 |
95 |
re Langat virus (LGT) - with Kyle,
2002
|
| 59 |
96 |
re flaviviridae tick-borne encephalitis viruses (TBEV),
2004
|
| 59 |
97 |
re protective immune response against 1918 influenza virus,
c.2007
|
| |
Books Inscribed to Dr. Chanock,
1998-2004 [subseries]:
|
| 60 |
1 |
Textbook of Military Medicine - Part I Warfare, Weaponry and the Casualty,
1998
|
| 60 |
2 |
Hantavirus hunting - by Ho-Wang Lee,
2004
|
| |
Series 6: Meetings,
1954-2005 [series]:
|
| 60 |
3 |
Proceedings of the Conference on Complement Fixation,
5 August 1954
|
| 60 |
4-5 |
Proceedings of the Conference on Neutralization,
18-20 May 1955
|
| 60 |
6 |
Proceedings of the Round Table Conference on Genetic Aspects of Virus-Host Cell Relationships with Particular Reference to Polioviruses,
23-24 February 1956
|
| 60 |
7 |
Society for Pediatric Research annual meeting,
8-9 May 1959
|
| 60 |
8 |
Meetings - general,
1960
|
| 60 |
9 |
Meetings - general,
1961
|
| 60 |
10-11 |
Russian trip,
May 1961
|
| 60 |
12 |
Meeting in Prague, Czechoslovakia,
23-27 May 1961
|
| 60 |
13 |
World Health Organization, Geneva,
15-21 August 1961
|
| 60 |
14 |
Meetings - general,
1962
|
| 60 |
15 |
International Postgraduate Course Respiratory Virus Diseases,
11-14 April 1962
|
| 60 |
16 |
Newer Respiratory Disease Viruses,
3 October 1962
|
| 60 |
17 |
Meetings - general,
1963
|
| 60 |
18 |
World Health Organization Respiratory Virus meeting,
1-6 July 1963
|
| 60 |
19 |
University of Wisconsin Symposium on New Castle Disease,
15 July 1963
|
| 60 |
20 |
7th International Congress on Tropical Medicine,
1-11 September 1963
|
| 60 |
21 |
Seminar on Respiratory Disease,
9 October 1963
|
| 60 |
22 |
Meetings - general,
1964
|
| 60 |
23 |
American College of Physicians,
6-10 April 1964
|
| 60 |
24 |
World Health Organization directors,
20-27 July 1964
|
| 60 |
25 |
Meetings - general,
1965
|
| 60 |
26 |
Rhinovirus workshop,
25 January 1965
|
| 60 |
27 |
American Society of Clinical Investigation,
3 May 1965
|
| 60 |
28 |
World Health Organization,
27 September 1965
|
| 60 |
29 |
Armed Forces Epidemiological Board Commission on Viral Infections,
14-15 October 1965
|
| 60 |
30 |
International Congress of Pediatrics,
7 November 1965
|
| 60 |
31 |
Conference on Acute Infectioius Respiratory Diseases,
14-15 December 1965
|
| 60 |
32 |
Meetings - general,
1966
|
| 60 |
33 |
Mycoplasma conference,
9-11 February 1966
|
| 60 |
34 |
American Society for Clinical Investigation,
1 May 1966
|
| 60 |
35 |
New York Academy of Science,
11 May 1966
|
| 60 |
36 |
Conference on Live Oral Adenovirus Vaccine in Marine and Navy Recruits,
10-11 June 1966
|
| 61 |
1 |
Pan American Health Organization,
7 November 1966
|
| 61 |
2 |
Meetings - general,
1967
|
| 61 |
3-4 |
Human Vaccines - Possible Oncogenic Implications,
9 January 1967
|
| 61 |
5 |
Laboratory Methods in the Isolation and Identification of Respiroviruses and Enteroviruses,
3-4 July 1967
|
| 61 |
6 |
Respiratory Syncytial Virus Workshop,
10 July 1967
|
| 61 |
7 |
Conference on Measles Virus, etc.,
13 September 1967
|
| 61 |
8 |
Scientific Group on Respiratory Viruses,
9-14 October 1967
|
| 61 |
9 |
American Academy of Pediatrics,
25 October 1967
|
| 61 |
10 |
Symposium honoring Dr. M. D. Eaton,
1 December 1966
|
| 61 |
11 |
Meetings - general,
1968
|
| 61 |
12 |
Clinical at the College of Physicians and Surgeons, Columbia, University,
27 January 1968
|
| 61 |
13-14 |
Gustav Stern Symposium on Perspectives in Virology,
29 January 1968
|
| 61 |
15 |
American Academy of Allergy,
5-7 February 1968
|
| 61 |
16 |
American Epidemiological Society,
29-30 March 1968
|
| 61 |
17 |
American Medical Association,
23-24 April 1968
|
| 61 |
18 |
American Society for Clinical Investigation,
5 May 1968
|
| 61 |
19 |
Society for Epidemiological Research,
10-11 May 1968
|
| 61 |
20 |
Postgraduate Workshop, University of Maryland,
2 June 1968
|
| 61 |
21 |
Third International Symposium on Aerobiology,
15-19 September 1968
|
| 61 |
22 |
Influenza Genetics,
11-12 November 1968
|
| 61 |
23 |
Armed Forces Epidemiological Board Committee on Influenza,
18-20 November 1968
|
| 61 |
24 |
Twelfth International Congress of Pediatrics,
1-7 December 1968
|
| 61 |
25 |
Meetings - general,
1969
|
| 61 |
26 |
Vaccine Development Committee meeting,
27-28 January 1969
|
| 61 |
27 |
International Conference on Rubella Immunizations,
18-20 February 1969
|
| 61 |
28 |
Conference on Immunology,
2 April 1969
|
| 61 |
29-30 |
World Health Organization Virus Reference Centres meeting,
22-25 April 1969
|
| 61 |
31 |
American Society for Microbiology,
4-9 May 1969
|
| 61 |
32 |
American Society for Clinical Investigation,
5 May 1969
|
| 61 |
33 |
American Thoracic Society,
24-26 May 1969
|
| 61 |
34 |
Gustav Stern meeting,
25-26 May 1969
|
| 61 |
35 |
Ad hoc Conference on Australia Antigen and Hepatitis,
23-24 June 1969
|
| 61 |
36 |
Vaccine Development Workshop on Vaccine Testings,
27 June 1969
|
| 61 |
37 |
Virus Diseases of the Respiratory Tract,
23 September 1969
|
| 61 |
38 |
International Working Conference on Influenza,
14-16 October 1969
|
| 61 |
39 |
Infectious Disease Society of America,
25-26 October 1969
|
| 61 |
40 |
International Conference on Vaccines against Viral and Rickettsial Diseases of Man,
7-11 November 1969
|
| 61 |
41 |
Committee on Influenza,
17-19 November 1969
|
| 61 |
42 |
NICHD Immunology Workshop,
11-13 December 1969
|
| 61 |
43 |
Secretory Antibody,
10-13 December 1969
|
| 61 |
44 |
Human Responses to Viral Antigens,
3 August 1971
|
| 61 |
45 |
Mycoplasma and Mycoplasma-like Agents of Animal and Plant Diseases,
8-10 January 1973
|
| 61 |
46 |
Influenza Workshop IV,
24 January 1973
|
| 61 |
47 |
Acute Respiratory Diseases,
8-9 March 1973
|
| 61 |
48 |
Influenza Vaccines, University of Maryland,
13 March 1973
|
| 61 |
49 |
Fogarty Center Conferences on Preventive Medicine,
15-16 March 1973
|
| 61 |
50 |
ICN/UCLA Symposium on Molecular Biology-Virus Research,
18-23 March 1973
|
| 61 |
51 |
New Approaches for Inducing Natural Immunity to Pyogenic Organisms,
20-23 March 1973
|
| 61 |
52 |
Influenza Workshop V on Influenza Vaccines,
3-4, 14 April 1973
|
| 62 |
1 |
Influenza Workshop V on Influenza Vaccines (cont'd),
3-4, 14 April 1973
|
| 62 |
2 |
American Epidemiological Society,
6-7 April 1973
|
| 62 |
3 |
Epidemic Intelligence Service Conference,
9-13 April 1973
|
| 62 |
4-5 |
Directors of World Health Organization Reference Centers,
16-19 April 1973
|
| 62 |
6 |
U.S.-Japan Program,
23-27 July 1973
|
| 62 |
7-8 |
Problems of Bacteriophage Contamination,
1 August 1973
|
| 62 |
9 |
FIC Subcommittee on Infectious Diseases,
14-16 September 1973
|
| 62 |
10 |
Infectious Diseases Society of America,
17-18 September 1973
|
| 62 |
11 |
Parainfluenza and RS Candidate Vaccines,
5 October 1973
|
| 62 |
12 |
Animal Influenza and its Significance for Human Infections,
11-12 October 1973
|
| 62 |
13 |
University of Chicago Alumni Banquet,
23 October 1973
|
| 62 |
14 |
National Academy of Sciences,
23 October 1973
|
| 62 |
15 |
Interagency Meeting on Influenza,
19 November 1973
|
| 62 |
16-17 |
World Health Organization,
1-5 September 1975
|
| 62 |
18 |
Joint Working Conference of the Virus Cancer Program,
3-5 November 1975
|
| 62 |
19 |
Influenza meeting, NIH,
12 January 1976
|
| 62 |
20 |
Influenza Program Review meeting, NIH,
15-16 January 1976
|
| 62 |
21 |
Working Group on Pandemic Influenza,
26-28 January 1976
|
| 62 |
22 |
Bacterial and Viral Gastroenteritis,
5-6 February 1976
|
| 62 |
23 |
Bureau of Biologics,
20 February 1976
|
| 62 |
24 |
Walter Reed Ad Hoc meeting,
8 March 1976
|
| 62 |
25 |
Armed Forces Epidemiological Board,
12 March 1976
|
| 62 |
26 |
Bureau of Biologics,
25 March 1976
|
| 62 |
27 |
Current Status and Prospect for Improved and New Bacterial Vaccines,
29 March-1 April 1976
|
| 62 |
28 |
Influenza meeting, NIH,
15 April 1976
|
| 62 |
29 |
National Academy of Sciences,
26-28 April 1976
|
| 62 |
30 |
American Epidemiological Society,
29 April-1 May 1976
|
| 62 |
31 |
Association of American Physicians,
30 April-2 May 1976
|
| 62 |
32 |
American Society for Microbiology,
2-7 May 1976
|
| 62 |
33 |
Association of American Physicians,
4 May 1976
|
| 62 |
34 |
Conference on Persistent Viral Infections,
13-16 June 1976
|
| 62 |
35 |
Bureau of Biologics,
21-22 June 1976
|
| 62 |
36 |
Bronchiolitis workshop,
28-29 June 1976
|
| 62 |
37 |
Festschrift for Albert Sabin,
26 August 1976
|
| 62 |
38 |
Consensus Development on Use of Amantadine,
15-16 October 1976
|
| 62 |
39 |
Infectious Disease Society of America,
25-26 October 1976
|
| 62 |
40 |
Ad Hoc Viral and Rickettsial Disease Study Group,
8 November 1976
|
| 62 |
41 |
Viral and Bacterial Vaccines, Present Knowledge and Future Development International Symposium,
7-8 September 1977
|
| 62 |
42 |
Chinese delegation,
1979
|
| 62 |
43 |
Experimental Herpesvirus Vaccine workshop,
7-9 February 1979
|
| 62 |
44 |
Surgeon General's Meeting on Influenza,
12 February 1979
|
| 62 |
45 |
Medical Research Council,
20 February 1979
|
| 62 |
46 |
Symposium on Potentiation of Immune Response to Vaccines,
20-21 February 1979
|
| 62 |
47 |
The Royal Society Meeting on Influenza,
21-22 February 1979
|
| 63 |
1 |
Secretary's Conference on Influenza,
6 March 1979
|
| 63 |
2 |
Attenuated Influenza Vaccine workshop, NIH,
9 March 1979
|
| 63 |
3 |
American Physicians Fellowship Program, NIH,
29-30 March 1979
|
| 63 |
4 |
American Epidemiological Society,
30-31 March 1979
|
| 63 |
5 |
Vaccine Studies in the Elderly,
30 April 1979
|
| 63 |
6 |
American Society for Microbiology,
4-11 May 1979
|
| 63 |
7 |
Influenza B Viruses workshop,
30-31, 1979
|
| 63 |
8 |
Prevention of Major Infectious Diseases: Current Concerns and Future Promise,
20-21 September 1979
|
| 63 |
9 |
Medical Society of the District of Columbia,
27-28 September 1979
|
| 63 |
10 |
Infectious Diseases Society of America,
5-6 October 1979
|
| 63 |
11 |
Molecular Approaches to Vaccine Development,
10 October 1979
|
| 63 |
12 |
U.S.-U.S.S.R. Influenza meeting,
16-18 October 1979
|
| 63 |
13 |
Genetic Variation of Viruses,
28-30 November 1979
|
| 63 |
14 |
Australian Commonwealth Scientific and Industrial Research Organization,
10-12 December 1979
|
| 63 |
15 |
Perspectives in Virology,
4-5 February 1980
|
| 63 |
16 |
Australian Academy of Science,
8-12 February 1982
|
| 63 |
17 |
Duke University seminar,
4 February 1980
|
| 63 |
18 |
Attenuated Vaccines,
10 March 1980
|
| 63 |
19 |
Pritzker School of Medicine Council meeting,
2 May 1980
|
| 63 |
20 |
American Society for Microbiology,
11-16 May 1980
|
| 63 |
21 |
Eradication of Infectious Diseases,
27-28 May 1980
|
| 63 |
22 |
Infectious Disease Society of America,
25-26 September 1980
|
| 63 |
23 |
Negative Strand Viruses,
27 October-1 November 1980
|
| 63 |
24 |
World Health Organization Consultation on Influenza,
5-6 November 1980
|
| 63 |
25 |
Department of Microbiology and Molecular Genetics seminar,
2 December 1980
|
| 63 |
26 |
ICN/UCLA Symposium on Genetic Variation of Influenza Viruses,
8-13 March 1981
|
| 63 |
27 |
International Symposium on Viral Hepatitis,
30 March-2 April 1981
|
| 63 |
28 |
Department of Microbiology and Immunology seminar, Duke University,
16 April 1981
|
| 63 |
29 |
Mt. Sinai Symposium on Infections Caused by Enteric Viruses,
4 June 1981
|
| 63 |
30 |
International Congress of Virology,
2-7 August 1981
|
| 63 |
31 |
Respiratory Diseases meeting,
16 October 1981
|
| 63 |
32 |
Workshop on Respiratory Diseases,
21-22 June 1982
|
| 63 |
33 |
International Symposium on Polilomyelitis Control,
14-17 March 1983
|
| 63 |
34 |
NIAID Workshop on AIDS,
5-6 April 1983
|
| 63 |
35 |
Towards New Vaccines Against Virus Infections,
21-23 June 1983
|
| 63 |
36 |
London Conference on Influenza,
21-23 September 1983
|
| 63 |
37 |
Association of American Physicians,
29 April-2 May 1983
|
| 63 |
38-47 |
Modern Approaches to Vaccine,
31 August-4 September 1983
|
| 63 |
48 |
Negative Strand Virus meeting,
11-17 September 1983
|
| 63 |
49 |
International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections,
9-12 October 1983
|
| 63 |
50 |
19th Immunization Conference - proceedings,
21-24 May 1984
|
| 63 |
51 |
International Congress of Virology,
1-7 September 1984
|
| 63 |
52 |
International Workshop on the Molecular Biology of Flaviviruses,
29 November-1 December 1984
|
| 63 |
53 |
Status of Attenuated Influenza Vaccines,
10-11 December 1984
|
| 63 |
54 |
Rowe Symposium,
11-12 February 1985
|
| 63 |
55 |
Rotavirus Vaccine Work Group,
13 March 1985
|
| 63 |
56 |
Genetically Altered Viruses,
28 April-1 May 1985
|
| 64 |
1 |
American Society for Virology,
21-25 July 1985
|
| 64 |
2 |
World Health Organization Steering Committee on Acute Respiratory Viruses,
29-30 July 1985
|
| 64 |
3-5 |
Modern Approaches to Vaccines,
11-15 September 1985
|
| 64 |
6 |
The Biology of Negative Strand Viruses,
15-20 September 1985
|
| 64 |
7 |
Expression of Foreign Genes,
4-7 October 1985
|
| 64 |
8 |
RSV Symposium,
16 October 1985
|
| 64 |
9 |
Duke University Academic Visiting Professor,
16-18 December 1985
|
| 64 |
10 |
Scripps Scientific Review Committee,
13-15 January 1986
|
| 64 |
11 |
Rowe Symposium,
3-4 February 1986
|
| 64 |
12 |
Vaccinia-Vectoring,
31 March 1986
|
| 64 |
13 |
Cosmos Club award, Albert Sabin,
15 April 1986
|
| 64 |
14 |
Vaccine Supply and Innovation workshop,
24-25 April 1986
|
| 64 |
15 |
Association of American Physicians,
2-4 Mary 1986
|
| 64 |
16 |
Influenza Viruses,
20 May 1986
|
| 64 |
17 |
World Health Organization Acute Respiratory Viruses meeting,
27-28 June 1986
|
| 64 |
18 |
FEBS meeting,
24-29 August 1986
|
| 64 |
19 |
Infectious Diseases Society of America,
2-3 October 1986
|
| 64 |
20 |
Scripps Scientific Review Committee,
10 January 1987
|
| 64 |
21 |
Rowe Symposium,
2-3 February 1987
|
| 64 |
22 |
AIDS Vaccines workshop,
25-27 March 1987
|
| 64 |
23 |
Workshop on Respiratory Syncytial and Parainfluenza Viruses,
4-5 May 1987
|
| 64 |
24 |
Scholars-in-Residence symposium,
11-14 May 1987
|
| 64 |
25 |
Pasteur Centenary Symposium,
26-28 May 1987
|
| 64 |
26 |
American Society for Virology,
31 May-4 June 1987
|
| 64 |
27 |
International Conference on AIDS,
1-5 June 1987
|
| 64 |
28-29 |
Nobel Symposium on the Vaccines of the Future,
23-26 August 1987
|
| 64 |
30 |
International Symposium on Infectious Diseases,
11-12 November 1987
|
| 64 |
31 |
Live Viral Vaccines for Respiratory and Enteric Tract Diseases,
24 November 1987
|
| 64 |
32 |
Conference on the Development of Vaccines Against HIV and AIDS,
14-15 December 1987
|
| 64 |
33 |
Scripps Scientific Review Committee,
14 January 1988
|
| 64 |
34 |
Conference on Poliomyelitis Vaccines: Re-evaluating Policy Options,
21-22 January 1988
|
| 64 |
35 |
Rowe Symposium,
1-2 February 1988
|
| 64 |
36 |
National Academy of Sciences Committee on International Security and Arms Control,
16 March 1988
|
| 64 |
37 |
Oral Immunization symposium,
21-22 March 1988
|
| 64 |
38 |
NIH Seminar,
6 April 1988
|
| 64 |
39 |
American Pediatric Society Centennial Celebration,
3 May 1988
|
| 64 |
40 |
National Academy of Sciences and Academy of Sciences of the USSR on Biological Weapons,
9-11 May 1988
|
| 64 |
41 |
Wagner Symposium,
15-16 May 1988
|
| 64 |
42 |
Live Attenuated Influenza Virus Vaccine,
26 May 1988
|
| 64 |
43 |
American Society for Virology,
12-16 June 1988
|
| 64 |
44 |
NIH Rotavirus Vaccine workshop,
8-9 September 1988
|
| 64 |
45 |
Modern Approaches to New Vaccines Including Prevention of AIDS,
14-18 September 1988
|
| 64 |
46 |
Immunology of Virus Diseases,
26-28 October 1988
|
| 64 |
47 |
Genetic Basis of Human Disease,
30 November-1 December 1988
|
| 64 |
48 |
Institute of Medicine Research Briefing Panel,
27-28 April 1989
|
| 64 |
49 |
Symposium on Respiratory Virus Vaccine Development,
1 May 1989
|
| 64 |
50 |
American Society for Virology,
9-13 July 1989
|
| 64 |
51-52 |
Modern Approaches to New Vaccines Including Prevention of AIDS,
20-24 September 1989
|
| 64 |
53 |
International Conference on Comparative and Applied Virology,
15-21 October 1989
|
| 64 |
54 |
Rowe Symposium,
5-6 February 1989
|
| 64 |
55-56 |
American Thoracic Society,
23 May 1990
|
| 65 |
1 |
American Thoracic Society (cont'd),
23 May 1990
|
| 65 |
2 |
International Congress of Virology,
26-31 August 1990
|
| 65 |
3 |
Children's Vaccine Initiative,
6 August 1990
|
| 65 |
4 |
Colloquium on Human Diseases - Molecular Mechanisms of Viral Pathogenesis,
19-20 October 1990
|
| 65 |
5 |
Animal Models of Respiratory Syncytial Virus Infections,
24-25 October 1990
|
| 65 |
6 |
NIH Rotavirus Vaccine Workshop,
5-6 November 1990
|
| 65 |
7 |
Rowe Symposium,
4-5 February 1991
|
| 65 |
8 |
Saul Krugman Festschrift,
12 April 1991
|
| 65 |
9 |
Inauguration of Richard M. Haidack Distinguished Professorship in Medicine,
29 May 1991
|
| 65 |
10 |
Pathogenesis Symposium,
5 December 1991
|
| 65 |
11 |
Rowe Symposium,
3-4 February 1992
|
| 65 |
12 |
NIAID Interdivisional AIDS Working Group,
24 April 1992
|
| 65 |
13 |
Measles workshop,
14-15 September 1992
|
| 65 |
14 |
Lounsbury Award Jury Dinner,
5 November 1992
|
| 65 |
15 |
Innovations in Therapy of Human Viral Diseases,
6-7 December 1992
|
| 65 |
16 |
Molecular Pathogenesis of Infections and Tumors,
5-6 May 1994
|
| 65 |
17 |
Scientific Symposium to Honor the Work of Janet W. Hartley,
13 September 1994
|
| 65 |
18 |
Scientific Meeting of the Australian Society for Microbiology,
26-30 September 1994
|
| 65 |
19 |
Molecular Approaches to the Control of Infectious Diseases,
5-9 October 1994
|
| 65 |
20-21 |
Frank and Bobbie Fenner Conference in Medical Research,
28-30 November 1994
|
| 65 |
22 |
Office of Science and Technology Policy meeting,
29 March 1995
|
| 65 |
23 |
Fogarty Advisory Board,
23 May 1995
|
| 65 |
24 |
Igor Tamm Memorial Symposium,
30 November 1995
|
| 65 |
25 |
Thomas Merigan Lecture,
23-29 May 1996
|
| 65 |
26 |
Conference on Immunoglobulins,
2-4 June 1996
|
| 65 |
27 |
Antibody workshop,
2-4 June 1996
|
| 65 |
28 |
Simian Virus 40 workshop,
27-28 January 1997
|
| 65 |
29-30 |
NIAID Principal Investigators' retreat,
20-21 November 1997
|
| 65 |
31 |
Center for Biologics Evaluation and Research, Vaccines and Related Biological Products Advisory Committee,
19-20 Novebmer 1998
|
| 65 |
32 |
American Epidemiological Society,
18-19 March 1999
|
| 65 |
33 |
Memorial Symposium for Robert Huebner,
11 November 1999
|
| 65 |
34 |
Conference on Vaccine Research,
1-2 May 2000
|
| 65 |
35 |
NIAID Principal Investigators' workshop,
6-7 November 2000
|
| 65 |
36 |
NIAID Principal Investigators' workshop,
14-15 November 2002
|
| 65 |
37 |
RSV 2003 Symposium,
8-11 November 2003
|
| 65 |
38 |
Trans-NIH/FDA Intramural Biodefense Symposium,
7-8 April 2004
|
| 65 |
39 |
Rotavirus Symposium,
7-9 July 2005
|
| 65 |
40 |
RSV Symposium,
15-18 September 2005
|
| |
Series 7: Lectures and Speeches,
1951-2005 [series]:
|
| 65 |
41 |
Control of pediatric viral diseases: past successes and future prospects,
undated
|
| 65 |
42 |
Untitled ["There seems little reason to doubt that antibody in serum is an important mediator"],
c.1950s
|
| 65 |
43 |
Hemagluttination with the virus of western equine encephalitis - with Sabin,
30 November 1951
|
| 65 |
44 |
Hemagglutinins of St. Louis and western equine viruses - isolation, properties, and use for diagnosis and epidemiologic survey,
5 May 1952
|
| 65 |
45 |
The Hemagglutination test for Japanese encephalitis, a diagnosis and survey tool,
1955
|
| 65 |
46 |
Untitled ["I'd like to start off by describing in some detail, of course I'll probably be offending some, viruses and some of the tests we use in"],
25 November 1958
|
| 65 |
47 |
Mycoplasma pneumoniae infections - prospects for live and inactivated vaccines,
c.1963
|
| 65 |
48 |
Infections caused by mycoplasmas,
4 November 1965
|
| 65 |
49 |
Australia antigen and serum hepatitis,
1970
|
| 65 |
50 |
Untitled [at International Congress of Microbiology],
August 1970
|
| 65 |
51 |
Parainfluenza virus epidemiology,
3 May 1974
|
| 65 |
52 |
Untitled ["For approximately the past five years the Laboratory of Infectious Diseases at the NIH in Bethesda has been involved in the study of acute infectious nonbacterial gastroenteritis."],
September 1975
|
| 65 |
53 |
Untitled ["This morning I would like to discuss two areas of study in which we have been involved concerning human reovirus-like agent of infantile gastroenteritis.",
1976
|
| 65 |
54 |
Chicago talk,
1977
|
| 65 |
55 |
R. E. Dyer lecture,
30 May 1978
|
| 65 |
56 |
Medicine for Laymen series lecture,
4 December 1979
|
| 65 |
57 |
Smadel lecture at Infectious Diseases Society meeting,
26 September 1980
|
| 65 |
58 |
Saz Immunology Lecture,
9 October 1985
|
| 65 |
59 |
Successful strategy for selection and characterization of live poliomyelitis virus vaccine strains,
27 October 1986
|
| 66 |
1 |
Feldman Memorial Lecture,
17-18 March 1987
|
| 66 |
2 |
FAES lecture,
7 December 1988
|
| 66 |
3-4 |
Talamo lecture,
4 April 1990
|
| 66 |
5 |
Children's Hospital National Medical Center,
22 October 1990
|
| 66 |
6 |
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations,
7 February 1991
|
| 66 |
7 |
Careers in virology: a good beginning is usually required for a good ending,
7 or 12 February 1991
|
| 66 |
8 |
Albert Sabin eulogy,
1993
|
| 66 |
9 |
Natural history of RSV,
1994
|
| 66 |
10-11 |
Sabin Lecture, Cold Spring Harbor,
September 1995
|
| 66 |
12 |
Untitled ["sabin.doc"],
1997
|
| 66 |
13 |
Huebner Symposium lecture,
10 November 1999
|
| 66 |
14 |
Speech in honor of Brian Murphy,
2003
|
| 66 |
15 |
R. Walter Schlesinger, M.D. (1913-2003),
5 November 2003
|
| 66 |
16 |
Tribute to Albertk Kapikian, honored with Albert Sabin Foundation Gold Medal,
16 May 2005
|
| |
Series 8: Videocassettes,
1985-1987 [series]:
|
| 67 |
|
Wallace P. Rowe Symposium [11 Umatic videocassettes],
12 February 1985
|
| 68 |
|
A Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday [9 Umatic, 5 vhs videocassettes],
26 August 1986
|
| 68 |
|
Bldg10/ACRF [1 Umatic videocassette],
11 May 1987
|
